Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects

Piero Parchi(Case Western Reserve University), Armin Giese(University of Göttingen), Sabina Capellari(Case Western Reserve University), Paul Brown(National Institute of Neurological Disorders and Stroke), Walter Schulz‐Schaeffer(University of Göttingen), Otto Windl(University of Göttingen), Inga Zerr(University of Göttingen), Herbert Budka(University of Vienna), Nicolas Kopp(Hôpital Pierre Wertheimer), Pedro Piccardo(Indiana University – Purdue University Indianapolis), S. Poser(University of Göttingen), Amyn M. Rojiani(University of South Florida), Nathalie Streichemberger(Hôpital Pierre Wertheimer), Jean Julien(Centre Hospitalier Universitaire de Bordeaux), C Vital(Centre Hospitalier Universitaire de Bordeaux), Bernardino Ghetti(Indiana University – Purdue University Indianapolis), Pierluigi Gambetti(Case Western Reserve University), Hans A. Kretzschmar(University of Göttingen)
Cited by 1,445

Abstract

Phenotypic heterogeneity in sporadic Creutzfeldt-Jakob disease (sCJD) is well documented, but there is not yet a systematic classification of the disease variants. In a previous study, we showed that the polymorphic codon 129 of the prion protein gene (PRNP), and two types of protease-resistant prion protein (PrP(Sc)) with distinct physicochemical properties, are major determinants of these variants. To define the full spectrum of variants, we have examined a series of 300 sCJD patients. Clinical features, PRNP genotype, and PrP(Sc) properties were determined in all subjects. In 187, we also studied neuropathological features and immunohistochemical pattern of PrP(Sc) deposition. Seventy percent of subjects showed the classic CJD phenotype, PrP(Sc) type 1, and at least one methionine allele at codon 129; 25% of cases displayed the ataxic and kuru-plaque variants, associated to PrP(Sc) type 2, and valine homozygosity or heterozygosity at codon 129, respectively. Two additional variants, which included a thalamic form of CJD and a phenotype characterized by prominent dementia and cortical pathology, were linked to PrP(Sc) type 2 and methionine homozygosity. Finally, a rare phenotype characterized by progressive dementia was linked to PrP(Sc) type 1 and valine homozygosity. The present data demonstrate the existence of six phenotypic variants of sCJD. The physicochemical properties of PrP(Sc) in conjunction with the PRNP codon 129 genotype largely determine this phenotypic variability, and allow a molecular classification of the disease variants.


Related Papers

No related papers found

Powered by citation graph analysis